A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (12) , 1672-1676
- https://doi.org/10.1016/0959-8049(93)90102-l
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Bacillus Calmette-Guérin versus mitomycin intravesical therapy in superficial bladder cancer: Results of randomized trial after 21 months of follow-upUrology, 1992
- Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder CancerJournal of Urology, 1992
- Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerinUrology, 1991
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Comparison of Different Schedules of Cytostatic Intravesical Instillations in Patients with Superficial Bladder Carcinoma: Final Evaluation of a Prospective Multicenter Study with 419 PatientsJournal of Urology, 1990
- Use of Intravesical Bacillus Calmette-Guérin in the Treatment of Superficial Transitional Cell Carcinoma of the Bladder: An OverviewUrologia Internationalis, 1990
- Long-Term Mitomycin C Instillation After Transurethral Resection of Superficial Bladder Carcinoma: Influence on Recurrence, Progression and SurvivalJournal of Urology, 1984
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Role of intravesical mitomycin c in management of superficial bladder tumorsUrology, 1980